HNRNPA2B1 and non-small cell lung carcinoma: Previous studies showed that CACNA1G-AS1 could promote proliferation in hepatoma cells through the miR-2392/C1orf61 axis, and this lncRNA could also regulate the malignant phenotype of non-small cell lung cancer via the HNRNPA2B1 pathway [32–36].